Entero Healthcare Solutions IPO: Strong Day One Subscription, GMP Hints Premium Listing

Entero Healthcare Solutions Limited has officially opened its doors to public investors through an initial public offering (IPO), commencing today and running until February 13, 2024. The healthcare products distributor company has set an enticing price band for its IPO at Rs 1,195 to Rs 1,258 per equity share, aiming to raise Rs 1,600 crore, with Rs 1,000 crore targeted through the issuance of fresh shares.

The shares of Entero Healthcare Solutions Limited entered the grey market, commanding a premium of Rs 126, according to market observers. This early positive sentiment has sparked interest among potential investors, setting the stage for a potentially successful public offering.

As of 1:03 pm on the first day of bidding, the book build issue has garnered early traction, with a subscription rate of 0.06 times overall. Notably, the retail portion has been oversubscribed at 0.27 times, indicating strong interest from individual investors. The employees' portion of the public issue has seen a subscription rate of 0.21 times, while the NII (Non-Institutional Investors) portion stands at 0.02 times.

Key Details of Entero Healthcare Solutions IPO

Grey Market Premium (GMP): Market observers report a premium of Rs 126 for Entero Healthcare Solutions Limited shares in the grey market, signalling positive anticipation.

Opening Date: The IPO officially opened today, and investors have until February 13, 2024, to participate in the bidding process.

Price Band: The company has fixed the price band for the public issue at Rs 1,195 to Rs 1,258 per equity share, making it an attractive proposition for potential investors.

IPO Size: Entero Healthcare Solutions aims to raise Rs 1,600 crore through the book build issue, with Rs 1,000 crore designated for fresh share issuance.

Lot Size: Investors can apply for shares in lots, with one lot comprising 11 company shares.

Allotment Date: The finalization of share allocation is expected on February 14, 2024, post the closure of the subscription period.

Registrar: Link Intime India Private Limited has been appointed as the official registrar for the book build issue, ensuring a smooth and transparent process.

Listing Plans: The public issue is slated for listing on both BSE and NSE, providing investors with multiple trading options.

Listing Date: Adhering to the T+3 listing rule, Entero Healthcare Solutions IPO is anticipated to be listed on February 16, 2024, offering investors the opportunity to trade by the end of the week.

As the IPO progresses, analysts predict a surge in demand, driven by the healthcare industry's resilience and the company's robust fundamentals. Entero Healthcare Solutions Limited's foray into the public domain is anticipated to be met with enthusiasm from investors seeking exposure to the burgeoning healthcare sector.

Investors and market experts alike are closely monitoring the subscription numbers, with the oversubscription in the retail segment being a positive indicator of retail investors' confidence in the company's growth prospects. The company's strong IPO opening in the grey market is indicative of the market's positive sentiment towards the healthcare distributor.